These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 11824456

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Introduction to a mini-forum on "glyconutrients".
    McClain DA.
    Glycobiology; 2008 Sep; 18(9):651. PubMed ID: 18710891
    [No Abstract] [Full Text] [Related]

  • 23. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG.
    Clin Infect Dis; 2008 Feb 01; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Jun 25; 72(121):34751-958. PubMed ID: 17674484
    [Abstract] [Full Text] [Related]

  • 26. A legal assessment of FDA's new HACCP regulations.
    McNamara SH.
    Food Drug Law J; 1997 Jun 25; 52(1):39-47. PubMed ID: 10346708
    [No Abstract] [Full Text] [Related]

  • 27. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM.
    Food Drug Law J; 1996 Jun 25; 51(4):631-5. PubMed ID: 11797732
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.
    Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services.
    J Pain Palliat Care Pharmacother; 2004 Jun 25; 18(3):95-107. PubMed ID: 15364637
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Science works through law to protect consumers. FDA's expanding horizons.
    Milstead KL.
    J Am Diet Assoc; 1966 Mar 25; 48(3):187-91. PubMed ID: 5952176
    [No Abstract] [Full Text] [Related]

  • 33. Foods--adulteration involving hard or sharp foreign objects; compliance policy guide; availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Apr 01; 64(62):15774-5. PubMed ID: 10558459
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT, Hagie F, Keen CL, Gershwin ME.
    Clin Ther; 2007 Jan 01; 29(1):1-16. PubMed ID: 17379043
    [Abstract] [Full Text] [Related]

  • 37. Developments in food and drug law.
    Masoudi GF.
    Food Drug Law J; 2005 Jan 01; 60(2):107-16. PubMed ID: 16097088
    [No Abstract] [Full Text] [Related]

  • 38. Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients.
    Noonan C, Patrick Noonan W.
    Toxicology; 2006 Apr 03; 221(1):4-8. PubMed ID: 16497425
    [Abstract] [Full Text] [Related]

  • 39. A survey of developments in food and drug law from July 1998 to November 1999.
    Littlefield N, Hada NR.
    Food Drug Law J; 2000 Apr 03; 55(1):35-56. PubMed ID: 12296348
    [No Abstract] [Full Text] [Related]

  • 40. Regulatory initiatives for dietary supplements.
    FDA Consum; 2005 Apr 03; 39(1):27. PubMed ID: 15803593
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.